BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12931167)

  • 1. Malaria: to kill a parasite.
    Ridley RG
    Nature; 2003 Aug; 424(6951):887-9. PubMed ID: 12931167
    [No Abstract]   [Full Text] [Related]  

  • 2. Artemisinins target the SERCA of Plasmodium falciparum.
    Eckstein-Ludwig U; Webb RJ; Van Goethem ID; East JM; Lee AG; Kimura M; O'Neill PM; Bray PG; Ward SA; Krishna S
    Nature; 2003 Aug; 424(6951):957-61. PubMed ID: 12931192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial activity of artemisinins: identification of a novel target?
    Mercereau-Puijalon O; Fandeur T
    Lancet; 2003 Dec; 362(9401):2035-6. PubMed ID: 14697798
    [No Abstract]   [Full Text] [Related]  

  • 4. Malaria and iron: history and review.
    Weinberg ED; Moon J
    Drug Metab Rev; 2009; 41(4):644-62. PubMed ID: 19764831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives on the mechanism of action of artemisinins.
    Golenser J; Waknine JH; Krugliak M; Hunt NH; Grau GE
    Int J Parasitol; 2006 Dec; 36(14):1427-41. PubMed ID: 17005183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the Schistosoma mansoni molecular target for the antimalarial drug artemether.
    Lepore R; Simeoni S; Raimondo D; Caroli A; Tramontano A; Via A
    J Chem Inf Model; 2011 Nov; 51(11):3005-16. PubMed ID: 21995318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Plasmodium falciparum Ca(2+)-ATPase PfATP6: insensitive to artemisinin, but a potential drug target.
    Arnou B; Montigny C; Morth JP; Nissen P; Jaxel C; Møller JV; Maire Ml
    Biochem Soc Trans; 2011 Jun; 39(3):823-31. PubMed ID: 21599655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins.
    Uhlemann AC; Cameron A; Eckstein-Ludwig U; Fischbarg J; Iserovich P; Zuniga FA; East M; Lee A; Brady L; Haynes RK; Krishna S
    Nat Struct Mol Biol; 2005 Jul; 12(7):628-9. PubMed ID: 15937493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pumped up: reflections on PfATP6 as the target for artemisinins.
    Krishna S; Pulcini S; Moore CM; Teo BH; Staines HM
    Trends Pharmacol Sci; 2014 Jan; 35(1):4-11. PubMed ID: 24268763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance hampers our capacity to roll back malaria.
    Olliaro P
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation therapy for malaria.
    Gordeuk VR; Thuma PE; Brittenham GM
    Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria and natural products: what is the future of this long-lasting relationship?
    Taglialatela-Scafati O
    Future Med Chem; 2014 Mar; 6(4):365-7. PubMed ID: 24635518
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmodium falciparum malaria parasites display a THG-sensitive Ca2+ pool.
    Varotti FP; Beraldo FH; Gazarini ML; Garcia CR
    Cell Calcium; 2003 Feb; 33(2):137-44. PubMed ID: 12531190
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity.
    Mu LY; Wang QM; Ni YC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine effects on Plasmodium falciparum gene expression.
    Moormann AM; Hossler PA; Meshnick SR
    Mol Biochem Parasitol; 1999 Jan; 98(2):279-83. PubMed ID: 10080396
    [No Abstract]   [Full Text] [Related]  

  • 17. The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates.
    Haynes RK; Chan WC; Lung CM; Uhlemann AC; Eckstein U; Taramelli D; Parapini S; Monti D; Krishna S
    ChemMedChem; 2007 Oct; 2(10):1480-97. PubMed ID: 17768732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron chelation in antimalarial therapy].
    Pradines B; Millet J; Henry M
    Med Trop (Mars); 2003; 63(2):119-30. PubMed ID: 12910648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium falciparum sarco/endoplasmic reticulum Ca²⁺-ATPase PfATP6.
    Guimarães DS; Fonseca AL; Batista R; Comar Junior M; Oliveira AB; Taranto AG; Varotti Fde P
    Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):255-8. PubMed ID: 25946251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria. Signs of drug resistance rattle experts, trigger bold plan.
    Enserink M
    Science; 2008 Dec; 322(5909):1776. PubMed ID: 19095911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.